The studies reported here address the molecular events underlying the interactions of arrestins with the M 2 muscarinic acetylcholine receptor (mAChR). In particular, we focused on the role of receptor phosphorylation in this process. Agonist-dependent phosphorylation of the In contrast, phosphorylation at site P1 was dependent on site A2. In addition, sites A1 and A2 significantly affected the ability of the wild type and P1 and P2 mutant receptors to internalization and to interact with arrestin2. Substitution of asparagine and glutamine for the aspartates and glutamates at sites A1 or A2 did not influence receptor phosphorylation but did influence arrestin interaction with the receptor. We propose that the amino acids at sites A1 and A2 play important roles in agonist-dependent phosphorylation at sites P2 and P1, respectively, also play an important role in arrestin interactions with the M 2 mAChR.
Introduction
Two receptors have served as "models" for the regulation of GPCRs, namely the visual receptor rhodoposin (Rh) (1-5) and the β 2 -adrenergic receptor (β 2 AR) (6-10). These receptors have been shown to undergo rapid phosphorylation on specific serines and threonines (Ser/Thr) at their C-termini shortly after agonist stimulation. The phosphorylation of GPCRs has been shown to be the result of activation of either second messenger dependent kinases (e.g. PKA and PKC) (11) and/or G-protein coupled receptor kinases (GRKs) (10, 12, 13) . The phosphorylation of GPCRs by GRKs is dependent on agonist activation of the GPCR (10, 12, 13) . Unlike secondmessenger dependent kinases whose consensus sites have been well studied [reviewed in (14) ], the consensus sites for GRK mediated phosphorylation are poorly defined. However, studies with peptide substrates have suggested that acidic amino acids such as aspartate or glutamate (D or E) at positions either N-or C-terminal to the phosphorylatable Ser/Thr appear to be required to direct GRKs to their substrates (15-17).
Phosphorylation of GPCRs by GRKs is necessary for the recruitment of cytosolic adaptor proteins termed arrestins (18) , whose binding to the GPCRs impairs further interaction with Gproteins and results in desensitization, or attenuation of receptor signaling (9, 10, (19) (20) (21) . There are 4 cloned mammalian arrestin family members termed arrestins1-4 (22). Arrestins1 and 4 are found exclusively within the visual system while arrestins2 and 3 are expressed ubiquitously (22) . Studies of arrestin/Rh interaction have led to the creation of a model in which activation by light and subsequent phosphorylation of Rh by rhodopsin kinase (GRK1) are both required to positively regulate arrestin1 association with Rh (23, 24) .4 mechanism is believed to govern the association of the β 2 AR with the non-visual arrestins, arrestin2 and 3 (30) . The requirement for phosphorylation of either Rh or the β 2 AR to allow for arrestin interaction can be bypassed under certain conditions. For example, mutations in the phosphorylation-recognition domain of arrestins can lead to a partial activation of arrestin and allow arrestin to interact with Rh and β 2 AR mutants that are unable to undergo agonistdependent phosphorylation (28, 30) . Arrestin/receptor interactions still require agonist activation of these GPCRs, but since these arrestin mutants can bind to non-phosphorylated Rh or β 2 AR, these arrestins are referred to as "phosphorylation-independent" forms of arrestins.
Like Rh and the β 2 AR, the M 2 muscarinic acetylcholine receptor (M 2 mAChR) undergoes agonist-dependent phosphorylation (31) (32) (33) . However, the phosphorylation of the M 2 mAChR occurs at Ser/Thr in the third intracellular (i3) loop of the receptor (34, 35) rather than on the Cterminus as occurs with both Rh and the β 2 AR (28,30). Phosphorylation can occur at two clusters of Ser/Thr, phosphorylation site one (P1, amino acids 286-290) and phosphorylation site two (P2, amino acids 307-311) (Figure 1 ) (35) . Phosphorylation at either P1 or P2 can support the agonist-induced internalization of the M 2 mAChR in HEK cells; this internalization occurs via an arrestin-independent pathway (35, 36) . However, phosphorylation at P2 is required for desensitization and arrestin binding, while phosphorylation at P1 is unable to support either of these processes (35, 36) . Mutation of the Ser/Thr to alanines in P2 results in a loss of arrestin binding, even though phosphorylation can still occur at P1 (36) . Of interest, unlike phosphorylation-deficient mutants of Rh and the β 2 AR, the M 2 mAChR was unable to interact with "phosphorylation-independent" forms of arrestin when P2 was mutated (37) . This result was surprising given that the model of arrestin/receptor interaction developed from studies of Rh and the β 2 AR suggested that the role of phosphorylation of the GPCR was to help trigger 5 activation of arrestin (23) (24) (25) (26) 38) . Since the P2 mutant of the M 2 mAChR was unable to bind to "phosphorylation-independent" forms of arrestin, these results suggested that different molecular events participate in the interaction of arrestins with the M 2 mAChR compared to those governing the interactions of arrestins with Rh or the β 2 AR. In particular, the results suggested that phosphorylation of the M 2 mAChR at P2 might not be serving to activate arrestins in the same manner as phosphorylation of Rh or the β 2 AR (37). In a recent study, we demonstrated that a phosphorylation-deficient M 2 mAChR was able to interact with arrestin2 or 3 if 15 amino acids surrounding P2 (amino acids 304-319) were deleted (37) . These data indicated that P2 and surrounding amino acids were acting as an inhibitory element to preclude arrestin binding in the absence of phosphorylation of P2 (37) . In the present study we have sought to further elucidate the molecular determinants of arrestin interactions with the M 2 mAChR. In particular we have focused on the role of specific amino acids in between sites P1 and P2 in regulating agonistdependent phosphorylation, internalization and arrestin/receptor interaction. Cell Culture and Transfection: HEK-tsA201 cells (human embryonic kidney cells stably expressing simian virus 40 large T antigen) were cultured as described (39) . HEK-tsA201 cells were transfected using the calcium phosphate precipitation method followed by a rinse with 4 mls of culture medium and incubated with fresh culture medium until cells were utilized for assays 48-72 hrs post-transfection. Cells were transfected with 10 µg of receptor cDNAs and ) was analyzed by Western blotting as previously described (39) .
Results and Discussion
In order to investigate the role of specific acidic amino acids in between the P1 and P2 phosphorylation clusters in the phosphorylation of the M 2 mAChR and the role of these acidic amino acids on receptor interaction with arrestins, a series of mutants were made in which acidic amino acids between P1 and P2 were mutated (Fig. 1) . The mutations were made in wild-type (WT), P1 mutant (*P1), and P2 mutant (*P2) backgrounds (35 we predicted that the physiological target of phosphorylation was at P2 (35, 36) . However, this prediction had not been directly tested.
We first tested a series of mutations prepared in the context of the wild-type (WT)
receptor to measure the effects of mutating the acidic amino acids on receptor phosphorylation (Fig. 2) . The agonist-dependent phosphorylation of a WT receptor in which acidic amino acids at site A1 were converted to alanines (WT*A1, Fig. 1 ) was reduced to 21 ± 6.8% of control WT receptor (Fig. 2) . In contrast, mutation of amino acids at site A2 to alanines in the WT receptor, WT*A2 (Fig. 1 ) had no effect on agonist-induced phosphorylation (Fig. 2) . Mutation of both acidic clusters in the WT receptor, WT*A1A2 (Fig. 1 ) resulted in a receptor that was phosphorylated only to 20 ± 2.7% of control, similar to WT*A1. These results indicated that A1
played an important role in directing the agonist-dependent phosphorylation of the M 2 mAChR.
Previous results demonstrated that P1 or P2 could serve as equivalent substrates of phosphorylation when either cluster was mutated to alanines (35) , but it was unclear whether both clusters might be partially phosphorylated in the context of the WT receptor, or whether P2, as hypothesized, was the main target of phosphorylation. To investigate the relative contributions of P1 or P2 in the agonist-dependent phosphorylation of the M 2 mAChR, the ability of the *P1 or *P2 mutants (see Fig. 1 ) to undergo agonist-dependent phosphorylation was examined in the presence and absence of mutations of A1 or A2. The effects of A1 and A2 on P2 phosphorylation were examined in the *P1 receptor background (Fig. 3) . The agonistdependent phosphorylation of *P1A1 was reduced to 42 ± 1.4% of control (control is defined as the phosphorylation of *P1, Fig. 3 ), while phosphorylation of *P1A2 was comparable to control (compare 96 ± 5.8% to control). Mutation of both acidic clusters in *P1A1A2 reduced phosphorylation to 28 ± 8.9% of control, similar to the *P1A1 mutant (Fig. 3) . These results indicated that the acidic amino acids at A1 were important in directing phosphorylation at P2.
Importantly, the effects of the A1 mutation were similar in both the WT and P1 mutant receptors, providing evidence for the hypothesis that P2 contains the preferred sites of phosphorylation in the WT receptors.
Next we analyzed the effects of mutating A1 and A2 in the context of *P2 (see Fig. 1 ) to measure the effects on phosphorylation at P1 ( Previous studies that have examined the role of acidic amino acids in the phosphorylation of GPCRs have generally only examined the role of mutating the acidic amino acids to alanines on the phosphorylation of peptide substrates (15-17). To examine whether the acidity of the amino acids was in fact required for directing phosphorylation at P2, we analyzed the ability of mutants with conservative substitutions of the aspartates and glutamates in A1 and A2 to asparagines and glutamines (WT*A1QN and WT*A2QN, Fig. 1 ) to undergo agonist-dependent phosphorylation. We anticipated that if acidity at A1 were important in directing the agonistdependent phosphorylation of P2, substitution of asparagine and glutamine for the aspartate and glutamate residues at A1 would inhibit the extent of phosphorylation observed in the WT receptor. We further predicted that conservative substitutions made at A2 would have no effect on the agonist-dependent phosphorylation in the WT receptor as A2 appears unimportant in directing phosphorylation at P2 (Fig. 3) . Unexpectedly, the WT*A1QN mutant was fully phosphorylated compared to control ( Fig. 5) indicating that conservative substitution of the acidic amino acids at A1 was sufficient to maintain full agonist-dependent phosphorylation in the M 2 mAChR. The WT*A2QN mutant was also unchanged in the extent of phosphorylation as compared to the WT control ( Fig. 5 ). These results are summarized in Table 2 .
Since the results discussed previously ( Fig. 2-4 ) demonstrated that P2 was the target of phosphorylation in the WT receptor, we interpret these findings to indicate that conservative substitution of the glutamates and aspartates in A1 to asparagine and glutamine was able to support phosphorylation at P2 in the WT M 2 mAChR background. Taken together, these results indicated that A1 and A2 participated in the agonist-dependent phosphorylation of the M 2 mAChR at both P1 and P2. While previous studies have implicated acidic amino acids as contributing to the agonist-dependent phosphorylation of GPCRs (15-17), the data presented here indicate that the acidic nature of the residues may be less important than the chemical nature of the residues. Replacement of the aspartic and glutamic acids with the conservative substitutions of asparagine and glutamine had no effect on the agonist-dependent phosphorylation in the M 2 mAChR. As described, no effect on the agonist-dependent phosphorylation at P1 was observed when A1 was mutated to alanines ( Fig. 4) , but phosphorylation at P2 was decreased when A1
was replaced with alanines ( Fig. 3) . As the conservative substitutions were studied in the WT background with both P1 and P2 present, we can not discriminate between effects of these substitutions on the phosphorylation at P1 vs. P2. However, it is likely that P2 remained the target in the WT*QN mutants. Identifying the effects of conservative substitutions on the phosphorylation at P1 or P2 would allow us to understand the contributions of the conservative substitutions at A1 and A2 on the phosphorylation of individual clusters, but due to technical difficulties, these mutants were unable to be created. However, the results with alanine- Of interest, alanine substitution of the different clusters of acidic amino acids differentially modulated the phosphorylation at the two Ser/Thr clusters. Phosphorylation at P1
was dependent on A2, while phosphorylation at P2 was dependent on A1. The contrasting roles of A1 and A2 on phosphorylation at P1 or P2 suggested the possibility that different kinases may have acted to phosphorylate the M 2 mAChR at P1 and P2. The phosphorylation of P2 was affected by alanine substitution of the acidic amino acids N terminal to the Ser/Thr phosphoacceptor sites, similar to the effects on phosphorylation sites proposed for GRK2 (16) .
In contrast, the phosphorylation of P1 was affected by alanine substitution of acidic amino acids C-terminal to the Ser/Thr phosphoacceptor sites. This resembled the described requirements for phosphorylation of peptides by GRK1 (16) . Thus different kinases may have catalyzed the phosphorylation of P1 and P2. In support of the possibility that more than one kinase may be participating in the agonist-induced phosphorylation of the M 2 mAChR, are results that demonstrated that expression of dominant-negative GRK2 reduced phosphorylation of the M 2 mAChR by approximately 50% and ablated desensitization, while having no effect on the phosphorylation-dependent internalization of this receptor (34) . An alternative explanation exists for the difference in the sensitivity of the phosphorylation of P1 and P2 to the presence of the acidic amino acids either N-or C-terminal to the phosphorylation sites. It is possible that the same kinase may have phosphorylated both sites but "read" the substrate in reverse directions.
As the sequence of P1 (STSVS) is almost a mirror image of P2 (TVSTS), it could be that P1 was read in a reverse direction than P2. In this reverse direction, A2 would be "upstream" of the P1 phosphorylation sites. Further studies are required to identify the kinase(s) involved in the agonist-dependent phosphorylation of sites P1 and P2.
Effect of acidic amino acid clusters on M 2 mAChR internalization.
Agonist-dependent phosphorylation of the M 2 mAChR has been demonstrated to influence arrestin-dependent and independent internalization (37) . Since mutation of A1 and A2 influenced M 2 mAChR phosphorylation, we examined the effects of these mutations on the internalization of the M 2 mAChR in HEK-tsA201 cells. We first examined the effects of A1 and A2 mutations on the internalization of the M 2 mAChR by the endogenous internalization machinery in HEK cells.
Internalization of the receptors by this machinery normally occurs via an arrestin-and dynaminindependent pathway (36) . The internalization of the WT receptor by this endogenous pathway was affected to a small degree when either A1 or A2 were mutated (Fig. 6 ). There appeared to be a slight, but statistically insignificant increase in the internalization of WT*A1 at 30 and 60 minutes (compare 37 ± 3.6% vs. 50 ± 7.7% at 30 min, and 45 ± 5.6% vs. 57 ± 5.9% at 60 min, for WT or WT*A1, respectively, Fig. 6 ). On the other hand, the mutation of both A1 and A2
markedly affected internalization at early time points. The internalization of WT*A1A2 was inhibited at 5 and 15 minutes compared to WT (14 ± 7.9% vs. -30 ± 8.7% at 5 min, 35 ± 9.1% vs. 8.3 ± 5.9%, at 15 min for WT or WT*A1A2, respectively, Fig. 6 ).
We next examined the effects of A1 and A2 mutations on the internalization of the P1 and P2 mutants. The internalization of *P1A2 at 5 min was delayed compared to *P1 [compare 5.2 ± 3.1% (*P1) to -9.6 ±8.7% (*P1A2); Fig. 7 ]. Interestingly, there was no internalization of *P1A1A2 at any time point examined (Fig. 7) . Rather, there appeared to be an agonistdependent recruitment of these mutant receptors to the cell surface as the number of cell surface receptors was increased as a function of carbachol treatment. The internalization of *P2 mutants was also influenced by mutation of A1 and/or A2 (Fig. 8) . Surprisingly, *P2A1 demonstrated an enhanced internalization compared to *P2 at all time points (Fig. 8) . In contrast, the internalization of the *P2A2 and *P2A1A2 mutants was markedly decreased in the rate and extent of internalization as compared to *P2 alone (Fig. 8) . These results indicated that the internalization of the M 2 mAChR by the endocytic machinery in HEK-tsA201 cells was influenced by the acidic amino acid clusters at A1 and A2.
Was a loss in phosphorylation responsible for the delayed onset or decreased extent of internalization? The effects of mutating sites A1 and A2 on phosphorylation at P1 or P2 were not completely correlated with changes in internalization. In fact, a complex set of results emerged. Let us first consider how mutants with a reduction in phosphorylation at P2 behaved in internalization assays. Phosphorylation at P2 was reduced in the WT*A1 and *P1A1 receptors, while internalization was slightly enhanced in WT*A1 but was delayed in *P1A1. A similar loss in phosphorylation was observed at P2 in the WT*A1A2 and *P1A1A2 mutants, while internalization was more severely inhibited in these double A1A2 mutants than with the single A1 mutation. In fact, the *P1A1A2 mutant did not internalize. Thus, while a reduction in phosphorylation at P2 may have contributed to reduced internalization, it appears that the mutations at A1 and A2 have other effects on receptor internalization, independently of receptor phosphorylation. If we next consider how decreased phosphorylation at P1 impacted the internalization through the endogenous pathways in HEK-tsA201 cells, we observed that mutant *P2A2 exhibited decreased phosphorylation at P1 and a decreased rate of internalization.
However, mutant *P2A1A2 had a similar decrease in phosphorylation at P1 with no effect on internalization. Taken together, these results demonstrate that both phosphorylation and the acidic amino acid clusters at A1 and A2 can modulate internalization of the M 2 mAChR.
Analysis of the enhanced internalization of *P2A1. The *P2A1 receptors internalized at a faster rate and to a higher extent than the wild-type M 2 mAChR (Fig. 8) . In fact, the enhanced internalization of this receptor resembled that of wild-type M 2 mAChR in the presence of overexpressed arrestin2 (36) (and see Table 2 and Fig.10A vs. 10F). While previous studies have
shown that the internalization of wild-type and *P1 receptors can be increased by co-expressing arrestin2 or 3 with the receptors in HEK-tsA201 cells, the internalization of the M 2 mAChR in these cells proceeds in an arrestin-independent, dynamin-independent pathway (36). However, we questioned whether the enhanced internalization of *P2A1 was due in part to a gained use of the endogenous arrestin-and dynamin-dependent pathway found within these cells. We (Fig. 9A and 9B ). Significant inhibition of *P2A1 internalization due to the expression of dyn K44A was detected at 30 and 60 minutes of agonist treatment (Fig. 9A , compare 50 ± 7.2% to 14.5 ± 7.7% and 49 ± 9.5% to 25 ± 6.3% in the absence and presence of dyn K44A at 30 and 60 minutes, respectively). At earlier time points, the inhibition due to the dyn K44A was not statistically significant, although there appeared to be a trend of inhibition at 5 and 15 minutes (Fig. 9A) . These results suggested that *P2A1
internalized by both the dynamin-sensitive and insensitive pathways. The enhanced internalization of *P2A1 was inhibited markedly by expression of the dominant-negative arr3(293-405) (Fig. 9B) , indicating that *P2A1 was using endogenous arrestin machinery to internalize in addition to the dynamin-and arrestin-independent pathway characterized for the M 2 mAChR (36). Interestingly, the enhanced internalization of *P2A1 that was due to use of endogenous arrestin machinery (Fig. 9 ) occurred in the absence of phosphorylation at P2, which has been shown to be necessary for arrestin binding in the WT and *P1 receptors (36) , and in the presence of full phosphorylation at P1 (Fig. 4) which has been shown to be unable to support arrestin interactions with the M 2 mAChR (36). The ability of *P2A1 to use endogenous arrestin machinery to internalize was unexpected. However, we can speculate that perhaps an arrestin binding site was created that was dependent on both the phosphorylation of P1 and the loss of acidic amino acids at A1. This binding site may have allowed for endogenous arrestin interaction with the M 2 mAChR. If full phosphorylation at P1 and loss of acidity at A1 created an M 2 mAChR that could interact with endogenous arrestin machinery, this could suggest that the acidic amino acids at A1 may contribute to the inability of the *P2 receptor to interact with endogenous or expressed arrestins. Furthermore, the gain-of-function *P2A1 mutant is interesting as it represents the first M 2 mAChR that can interact with the endogenous arrestin machinery in HEK cells. We speculate that the lack of phosphorylation of P1 in the wild type type M 2 mAChR does not interact with the endogenous arrestin-and dynamin-dependent internalization machinery in HEK cells. was not enhanced by co-expression of arrestin (Fig. 10B, C) . In marked contrast to WT*A1 and WT*A2, the mutant WT*A1A2 exhibited increased internalization in response to arrestin2 (Fig.   10D ).
Role of acidic amino acids on arrestin-promoted internalization.
Mutations of A1 and A2 in the context of the P1 mutant demonstrated similar patterns of arrestin-responsiveness as mutations made in the wild-type M 2 mAChR background ( Fig. 10E-H ). As shown previously (36), *P1 responded to over-expressed arrestin2 with an increased rate and extent of internalization (Fig. 10E) . However, mutants *P1A1 and *P1A2 were insensitive to arrestin2 co-expression ( Fig. 10F and 10G ). The *P1A1A2 mutant receptor, which no longer underwent agonist-dependent internalization when expressed alone in HEK-tsA201 cells, exhibited arrestin-enhanced internalization after agonist treatments of 30 and 60 minutes when arrestin2 was co-expressed (compare 14 ± 4.6% and 34 ± 9.6% internalization in the presence of arrestin2 co-expression with -9.4 ± 3% and -15.5 ± 11% in the absence of arrestin2 at 30 and 60 minutes, respectively, Fig. 10H ). . The *P2 mutant receptor did not exhibit arrestin-enhanced internalization (Fig. 10I ), in agreement with previous results (36) . The *P2A1 mutant also did not exhibit an increase in internalization when arrestin2 was co-expressed (Fig. 10J ). However, as described earlier, this receptor internalized faster and more extensively than the *P2 control in the absence of overexpressed arrestin2 (Fig. 8) , and the increased internalization was due to use of the endogenous arrestin-and dynamin-dependent internalization machinery (Fig. 9) . Thus, the inability of *P2A1
receptor to respond to arrestin2 over-expression was likely due to the saturation of the arrestindependent internalization machinery used by this receptor. Interestingly, the *P2A2 receptor exhibited arrestin-enhanced internalization after a delay of 30 and 60 minutes (Fig.10K) . In this respect the *P2A2 internalized with a similar pattern to *P1A1A2. The double acidic cluster mutant *P2A1A2 exhibited arrestin-enhanced internalization, similar to the *P2A2 mutant;
however, the effect of arrestin2 was evident at an earlier time point (Fig. 10L) . The extents of internalization that were observed at 30 minutes for the WT, *P1 and *P2 cluster acidic acid mutant receptors are summarized in Table 2 . These results indicated that mutation of the acidic amino acids between the P1 and P2 clusters influenced the ability of the M 2 mAChR to interact with arrestin2.
Effect of conservative mutations on the acidic amino acids affecting arrestin promoted
internalization. In order to investigate if the chemical/steric nature of the acidic amino acids participated in receptor interactions with arrestin, we studied the receptors in which the aspartic and glutamic acids of A1 and A2 were conservatively mutated to asparagine and glutamine in the wild-type M 2 mAChR background (WT*A1QN or WT*A2QN mutants, see Fig. 1 ). As described in Fig. 5 , the phosphorylation of these mutants was unchanged compared to control.
The WT*A1QN mutant exhibited decreased endogenous internalization and did not exhibit arrestin-enhanced internalization (Fig. 11A ). This receptor behaved similarly to the *P1A1 mutant (Fig. 10F) . Conversely, the WT*A2QN mutant exhibited arrestin2-enhanced internalization, despite a decreased endogenous internalization (Fig. 11B ). Since the WT*A2 mutant was arrestin-insensitive (Fig. 10C) , and the WT*A2QN mutant was arrestin-sensitive ( Fig. 11B) , this suggested that the chemical nature of the amino acid side chains at A2 were important in arrestin/M 2 mAChR interaction. Mutants with a neutralization of the aspartates and glutamates in A2 to asparagines and glutamines retained arrestin-sensitivity, while the mutants in which the acidic amino acids were changed to alanines lost arrestin sensitivity.
We anticipated that receptors that had A1 mutated to alanines would lose their ability to interact with arrestin2 due to the loss of phosphorylation at P2 when A1 was mutated to alanines (Fig. 2, 3) , and the requirement of a phosphorylated P2 cluster for M 2 mAChR/arrestin interaction (36) . The *P1A1 mutant had a significant loss in the extent of phosphorylation at P2, and was unable to interact with over-expressed arrestin2, supporting our hypothesis that a receptor deficient in P2 phosphorylation would be unable to interact with arrestins. Interestingly, there were receptors that had full phosphorylation at P2 that did not interact with arrestin2 (such as WT*A2 and *P1A2). This indicated that mutating A2 to alanines had direct consequences on arrestin/receptor interactions that were independent of the ability of P2 to undergo agonistdependent phosphorylation. Results with other mutants also indicated that other constraints influenced receptor/arrestin interactions. Interestingly, the *P2A1 and *P2A2 mutants which lost all phosphorylation at P2 were arrestin-sensitive. *P2A1 interacted with endogenous arrestin while *P2A2 exhibited arrestin-enhanced internalization when arrestin2 was co-expressed. These results demonstrated that phosphorylation at P2 was not sufficient, or always necessary, to support arrestin interactions with the M 2 mAChR.
Taken together, these results provided several new insights into events regulating receptor/arrestin interactions. First, phosphorylation at P2 was not in itself sufficient to promote arrestin/receptor interaction. Replacement of the acidic amino acids at A2 with alanines created receptors that underwent full phosphorylation at P2 (as in the WT*A2 and *P1A2 receptors, Fig. phosphorylation at P2 interacted with endogenous arrestin (*P2A1). Third, receptors that had a partial or complete loss of phosphorylation at P2 and alanine substitution of A2 (*P2A2, WT*A1A2, *P1A1A2, *P2A1A2) interacted with arrestin. The second class of mutants no longer interacted with arrestin and are arranged into 3 groups. The first arrestin-insensitive group were receptors that had lost phosphorylation at P2, but had A2 intact (e.g. *P2 WT*A1, and *P1A1). Next, if phosphorylation at P2 was unchanged, but A2 was mutated to alanines (as in WT*A2 and *P1A2), the M 2 mAChR was insensitive to arrestin2. Finally, conservative substitutions at A1 with no change observed in receptor phosphorylation (presumably at P2, the WT*A1QN receptor) created a receptor that did not respond to arrestin co-expression.
These findings highlight the complex interactions involving phosphorylation and A1 and A2 in governing receptor/arrestin interactions. However, it appears that P2 and A2 are primary determinants governing these interactions. We speculate that the role of phosphorylation at P2 in regulating arrestin interaction with the M 2 mAChR is to remove an inhibitory conformation that precludes arrestin binding in the absence of receptor phosphorylation at P2. The chemical interactions made by the aspartic and glutamic acids at A2 appeared to play a role in arrestin binding to the receptor as substitution with the chemically equivalent asparagine and glutamine maintained arrestin interaction, whereas substitution to alanines did not. We cannot exclude the possibility that the residues at A2 participated in the inhibitory conformation that precluded arrestin binding in the absence of M 2 mAChR phosphorylation at P2. Phosphorylation at P2 appeared to act to remove the inhibitory conformation that precluded arrestin binding when the receptor was in the unphosphorylated state, perhaps by destablizing a basal arrestin binding "inhibitory conformation" of the receptor. If the role of agonist-dependent phosphorylation at P2
were to remove an inhibitory constraint that A2 participates in, we would have expected to observe a regained ability of the M 2 mAChR to interact with arrestin2 upon alanine substitution of A2 and P2. Such a regained ability of the M 2 mAChR to interact with arrestin was in fact observed in *P2A2. The role of these residues on arrestin/receptor interaction was also observed in the double acidic cluster (*A1A2) mutants. WT*A1A2 exhibited a loss in phosphorylation at P2 due to mutation of A1, but underwent arrestin-enhanced internalization at every time point.
The *P1A1A2 mutant lost approximately 70% of its phosphorylation at P2 and the acidic residues at A2. *P1A1A2 did not undergo agonist-dependent internalization, like other phosphorylation-deficient M 2 mAChRs (36,37,43), yet arrestin2 promoted receptor internalization (Fig. 10H) . The arrestin-sensitivity of these receptors supported the hypothesis that a loss of phosphorylation at P2 and the removal of A2 would restore arrestin/receptor interaction.
These conclusions are also supported by studies examining deletion mutants of the M 2 mAChR and their ability to interact with arrestin2. Removal of the i3 loop of the M 2 mAChR created an arrestin2-sensitive receptor (37), much like WT*A1A2, *P1A1A2, *P2A2, and *P2A1A2 supporting the suggestion that phosphorylation at P2 in the M 2 mAChR acts to reverse an inhibitory constraint that precludes arrestin/receptor interaction. When as little as 15 amino acids (including P2) were removed from the i3 loop of the M 2 mAChR (amino acids 304-319), arrestin2 or 3 was able to interact with the M 2 mAChR in a P2 phosphorylation-independent manner (37). The results presented in this study indicated that the inhibitory element that is reversed upon phosphorylation at P2 might be composed minimally of A2 and P2. It appears that the chemical nature of the side chains of specific amino acids are involved in maintaining or regulating the ability of the M 2 mAChR to interact with arrestin.
Conclusions.
In conclusion, we have demonstrated multiple effects of acidic amino acids surrounding the phosphorylation sites in the M 2 mAChR. First, we demonstrated that these amino acids can influence phosphorylation sites that are either N-or C-terminal to the acidic amino acids. Second, the acidic nature of these amino acids was not necessary to direct agonistinduced phosphorylation, as receptors containing the neutral equivalents (asparagine or glutamine) were phosphorylated to the same extent as wild-type M 2 mAChR. Third, the acidic amino acids contributed to the ability of the receptor to internalize via the arrestin-insensitive internalization machinery present in HEK-tsA201 cells. These effects were not completely correlated with losses in phosphorylation. Fourth, the acidic amino acids influenced the ability of the M 2 mAChR to respond to arrestin co-expression in HEK-tsA201 cells in a manner that also was not completely correlated with their effects on receptor phosphorylation. Finally, novel insights into the structure-function relationships that contribute to the interaction of the M 2 mAChRs with arrestin2 were identified. It appears that an inhibitory element consisting of phosphorylation sites in the P2 cluster and A2, the amino acids located just N-terminal to the P2 cluster, may normally constrain the interaction of the M 2 mAChR with arrestins.
Phosphorylation at P2 appears to be sufficient to neutralize the inhibitory element to allow for arrestin interaction. experiments. *, p< .05 compared to control, using Student's t-test. experiments. *, p< .05 compared to control, using Student's t-test. 
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